Page 2 - Micro Interventional Devices News Today

NEWTOWN, Pa., May 27, 2021 /PRNewswire/ -- Micro Interventional Devices (MID) has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for its MIA-T Percutaneous

/PRNewswire/ -- Micro Interventional Devices (MID) has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for its MIA™-T...

Prosthetic Heart Valve Market to Witness Growth Acceleration During 2026 Prosthetic Heart Valve Market to Witness Growth Acceleration During 2026 BriefingWire.com, 5/06/2021 - Market Scenario Global Prosthetic Heart Valve market is expected to reach USD 8,392 Bn by 2026 at a CAGR of 9.5 % during the forecast period. The Global Prosthetic Heart Valve market is segmented based on type, end user region. By Product type - transcatheter valve, tissu...

Share this article NEWTOWN, Pa., Jan. 28, 2021 /PRNewswire/ -- Micro Interventional Devices, Inc.™ (MID) announced today that it has submitted the required technical documentation for CE Mark approval for its MIA-T™ Percutaneous Tricuspid Annuloplasty System for tricuspid valve repair to its Notified Body. The receipt of a CE Mark would allow MID to commercialize MIA-T in the European Union in countries governed by the European Medical Device Regulations (MDR).  MID is anticipating an ap...

Fior Markets which is the fastest growing market research company. The report provides a comprehensive scope of the market which includes future supply and demand scenarios, changing market trends, high growth opportunities, and in-depth analysis of the future market prospects. The report features real-time developments in the global Valvular Heart Disease Treatment market encompasses a highly structured and comprehensive outlook of the market. It shows market types and applications that are...